IMAC Holdings, Inc. (BACK)
NASDAQ: BACK · Real-Time Price · USD
0.656
-0.043 (-6.15%)
At close: Feb 21, 2025, 4:00 PM
0.690
+0.034 (5.18%)
After-hours: Feb 21, 2025, 6:55 PM EST
IMAC Holdings Revenue
IMAC Holdings had revenue of $56.30K in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $72.05K, down -100.57% year-over-year.
Revenue (ttm)
$72.05K
Revenue Growth
-100.57%
P/S Ratio
12.26
Revenue / Employee
$18,013
Employees
4
Market Cap
1.33M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
BACK News
- 3 days ago - Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay - GlobeNewsWire
- 12 days ago - Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response - GlobeNewsWire
- 26 days ago - IMAC Holdings Introduces Ignite Proteomics: A New Standard for Matching Patients with the Right Cancer Therapies - GlobeNewsWire
- 3 months ago - IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q - GlobeNewsWire
- 3 months ago - IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1) - GlobeNewsWire
- 5 months ago - IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology - GlobeNewsWire
- 8 months ago - IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors - GlobeNewsWire
- 9 months ago - IMAC Holdings Announces Leadership Succession - GlobeNewsWire